uri icon
  • Contact Info
  • 202-994-0899
  • Websites

Rohan Fernandes Faculty Member

Dr. Fernandes is an Associate Professor of Medicine at the George Washington University. The focus of his research is in the field of “immunoengineering.” A principal research area is the synthesis of modular nanoparticles, including biofunctionalized Prussian blue nanoparticles used for photothermal therapy, which can elicit robust responses from the immune system for the treatment of cancer and HIV. Dr. Fernandes and team have tested this modular nanoparticle-based approach to: improve drug delivery, elicit endogenous antitumor immune responses, as well as potentiate the function of immune effector cells such as T cells and NK cells in diverse cancer models and models of HIV latency. Dr. Fernandes completed his PhD in Bioengineering from the University of Maryland in 2008 and a postdoctoral fellowship from Johns Hopkins University in 2011. His research has been supported through multiple grants including R21, R33, R41, and R01 grants from the National Institutes of Health, an ‘A’ Award from Alex’s Lemonade Stand Foundation for Childhood Cancer, an Idea Award from the Department of Defense, and multiple industry-sponsored research agreements. Dr. Fernandes is also Founder and CEO of ImmunoBlue, LLC; a startup company to clinically translate and commercialize therapies developed by his research group.

Research Areas

GW Expert Finder utilizes up to four primary sources that shares data to populate individual profiles. Reference these FAQs for information on how to update your GW expert profile.
GW Expert Finder utilizes up to four primary sources that shares data to populate individual profiles. Reference these FAQs for information on how to update your GW expert profile.